BDO Wealth Advisors’s Myriad Genetics MYGN Stock Holding History

BDO Wealth Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-300	Closed	-$8K	–	1107
2021 Q4	$8K	Hold	300	–	–	﹤0.01%	763
2021 Q3	$10K	Hold	300	–	–	﹤0.01%	728
2021 Q2	$9K	Hold	300	–	–	﹤0.01%	770
2021 Q1	$9K	Hold	300	–	–	﹤0.01%	753
2020 Q4	$6K	Hold	300	–	–	﹤0.01%	619
2020 Q3	$4K	Hold	300	–	–	﹤0.01%	588
2020 Q2	$3K	Hold	300	–	–	﹤0.01%	599
2020 Q1	$4K	Buy	300 +100	+50%	+$2.11K	﹤0.01%	626
2019 Q4	$5K	Buy	200 +100	+100%	+$2.75K	﹤0.01%	491
2019 Q3	$3K	Sell	100 -200	-67%	-$5.83K	﹤0.01%	579
2019 Q2	$8K	Hold	300	–	–	﹤0.01%	462
2019 Q1	$10K	Hold	300	–	–	﹤0.01%	428
2018 Q4	$9K	Sell	300 -100	-25%	-$3.6K	﹤0.01%	421
2018 Q3	$18K	Buy	400 +100	+33%	+$4.45K	0.01%	391
2018 Q2	$11K	Hold	300	–	–	﹤0.01%	450
2018 Q1	$9K	Buy	+300	New	+$10.2K	﹤0.01%	407
2017 Q3	–	Sell	-300	Closed	-$8K	–	510
2017 Q2	$8K	Buy	+300	New	+$6.37K	﹤0.01%	400

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BDO Wealth Advisors's MYGN Position: Q1 2022 in Review

BDO Wealth Advisors sold out of Myriad Genetics (MYGN) in Q1 2022, closing a stake of 300 shares — an estimated $8K sold.

BDO Wealth Advisors first reported a position in MYGN in Q2 2017 and held it in 17 quarters. The position peaked at $18K in Q3 2018. 205 funds tracked by Wall St. Rank hold MYGN as of Q1 2022.

BDO Wealth Advisors reported no remaining Myriad Genetics position as of Q1 2022 after selling out during the quarter.
BDO Wealth Advisors sold 300 Myriad Genetics shares in Q1 2022, an estimated $8K.
BDO Wealth Advisors first reported a position in Myriad Genetics in Q2 2017 and held it in 17 quarters.
BDO Wealth Advisors's Myriad Genetics position peaked at $18K in Q3 2018.
205 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2022.

Based on BDO Wealth Advisors's 13F filing for Q1 2022, filed 6 May 2022.